Star Health and Allied Insurance Company (STARHEALTH) Fair Value & Analysis
Financial Services · IN · Market cap ₹341B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price +9.5% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹422.00 – ₹588.95 · fair‑value band ₹92.29 – ₹153.82 · the ₹580.30 price screens above the ₹123.06 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Star Health and Allied Insurance Company (STARHEALTH) currently trades at ₹580.30, while our model-based Fair Value estimate is ₹123.06 — implying the stock looks roughly 78.8% overvalued today. We read business quality at 67/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Star Health and Allied Insurance Company generated revenue of ₹178B at a net margin of 3.1%. Revenue grew 13.8% year over year. It earns a return on equity of 7.3%. The balance sheet holds a net cash position of ₹9.7B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments. In addition, it offers star health assure insurance policy, star cancer care platinum insurance policy, senior citizens health insurance policy, and star cardiac care insurance policy " platinum, as well as star group OPD care insurance product. The company offers its products through web aggregators, digital channels, agency channels, corporate …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Star Health and Allied Insurance Company reported revenue of ₹178B in FY2026 versus ₹106B in FY2022, a compound +13.9%/yr. Reported net income was ₹5.6B in FY2026.
Is STARHEALTH fairly valued? → Check now
Similar stocks
6 more Insurance - Life stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Ping An Insurance (Group) Company 601318 | ¥53.22 | ¥106.44 | +100% |
| China Life Insurance Company 601628 | ¥34.63 | ¥69.26 | +100% |
| AIA Group AAGIY | $37.75 | $46.53 | +23% |
| Manulife Financial Corporation MFC | $40.61 | $28.23 | -30% |
| China Pacific Insurance (Group) Co CHPXF | $3.65 | $5.82 | +59% |
| Aflac Incorporated AFL | $115.29 | $71.57 | -38% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Star Health and Allied Insurance Company (STARHEALTH) undervalued?
What is the fair value of STARHEALTH?
What is the quality score of STARHEALTH?
What is the revenue of Star Health and Allied Insurance Company (STARHEALTH)?
What is the net profit margin of STARHEALTH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.